Trials / Completed
CompletedNCT00213915
L-arginine Supplementation and Exercise; L-arginine Supplementation and Renal Function
Effects of Oral Chronic L-arginine Supplementation on Exercise and Renal Function of Heart Transplant Recipients
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (planned)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
* exercise capacities are still altered after heart transplantation partly due to peripheral endothelial dysfunction * cyclosporin-induced renal dysfunction may be due to renal endothelial dysfunction and can be reversed in an animal model by L-arginine supplementation * to determine the potential beneficial effect of L-arginine supplementation on exercise capacity and renal function of heart transplant recipients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 12 g of L-arginine glutamate during 6 weeks twice a day |
Timeline
- Start date
- 2004-02-01
- Completion
- 2004-12-01
- First posted
- 2005-09-21
- Last updated
- 2025-12-22
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00213915. Inclusion in this directory is not an endorsement.